175 related articles for article (PubMed ID: 24107412)
1. Evidence of the sensitivity of the MoCA alternate forms in monitoring cognitive change in early Alzheimer's disease.
Costa AS; Reich A; Fimm B; Ketteler ST; Schulz JB; Reetz K
Dement Geriatr Cogn Disord; 2014; 37(1-2):95-103. PubMed ID: 24107412
[TBL] [Abstract][Full Text] [Related]
2. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison.
Chang YT; Chang CC; Lin HS; Huang CW; Chang WN; Lui CC; Lee CC; Lin YT; Chen CH; Chen NC
Acta Neurol Taiwan; 2012 Jun; 21(2):64-73. PubMed ID: 22879115
[TBL] [Abstract][Full Text] [Related]
3. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
[TBL] [Abstract][Full Text] [Related]
4. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
[TBL] [Abstract][Full Text] [Related]
5. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
[TBL] [Abstract][Full Text] [Related]
6. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
7. Electroencephalogram global field synchronization analysis: a new method for assessing the progress of cognitive decline in Alzheimer's disease.
Ma CC; Liu AJ; Liu AH; Zhou XY; Zhou SN
Clin EEG Neurosci; 2014 Apr; 45(2):98-103. PubMed ID: 23986293
[TBL] [Abstract][Full Text] [Related]
8. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
9. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
[TBL] [Abstract][Full Text] [Related]
10. Microbleeds do not affect rate of cognitive decline in Alzheimer disease.
van der Vlies AE; Goos JD; Barkhof F; Scheltens P; van der Flier WM
Neurology; 2012 Aug; 79(8):763-9. PubMed ID: 22875093
[TBL] [Abstract][Full Text] [Related]
11. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
12. Correlation between cognitive function and the association fibers in patients with Alzheimer's disease using diffusion tensor imaging.
Meng JZ; Guo LW; Cheng H; Chen YJ; Fang L; Qi M; Jia ZY; Mohammed W; Hong XN
J Clin Neurosci; 2012 Dec; 19(12):1659-63. PubMed ID: 23062795
[TBL] [Abstract][Full Text] [Related]
13. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
14. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
Hansson O; Zetterberg H; Buchhave P; Londos E; Blennow K; Minthon L
Lancet Neurol; 2006 Mar; 5(3):228-34. PubMed ID: 16488378
[TBL] [Abstract][Full Text] [Related]
15. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
Schmand B; Huizenga HM; van Gool WA
Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ; Verhey F; Knol DL; Scheltens P; Wahlund LO; Freund-Levi Y; Tsolaki M; Minthon L; Wallin AK; Hampel H; Bürger K; Pirttila T; Soininen H; Rikkert MO; Verbeek MM; Spiru L; Blennow K
Lancet Neurol; 2009 Jul; 8(7):619-27. PubMed ID: 19523877
[TBL] [Abstract][Full Text] [Related]
18. Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages?
Capitani E; Cazzaniga R; Francescani A; Spinnler H
Neurol Sci; 2004 Oct; 25(4):198-204. PubMed ID: 15549505
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity.
Sämgård K; Zetterberg H; Blennow K; Hansson O; Minthon L; Londos E
Int J Geriatr Psychiatry; 2010 Apr; 25(4):403-10. PubMed ID: 19650161
[TBL] [Abstract][Full Text] [Related]
20. Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.
Rosselli MC; Ardila AC; Moreno SC; Standish VC; Arango-Lasprilla JC; Tirado VM; Ossa JM; Goate AM; Kosik KS; Lopera F
J Clin Exp Neuropsychol; 2000 Aug; 22(4):483-95. PubMed ID: 10923058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
